✨
AI Summary
- Cartesian Therapeutics' Dr. Metin Kurtoglu discusses the move to allogeneic RNA cell therapies.
- The company is developing Descartes-08, -11, and the allogeneic Descartes-25.
- The future of RNA cell therapy extends beyond rare diseases.
Guests on This Episode
MK
Metin Kurtoglu
1 podcast appearance